Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 702

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 702
---
559 |   |     |  116,811 |   |     |        1,819,370 |   |
| Cost of revenues(*)       |     |  (1,631,757 | ) |     | (242,981 | ) |     |       (1,874,738 | ) |
| Profit/(Loss) per segment |     |      70,802 |   |     | (126,170 | ) |     |          (55,368 | ) |

| Year ended June 30, 2023  |     |     Heritas 
 Diagnostics |   |     |   Rewell |   |     | Total as per the 
     statement of 
       operations |   |
|:--------------------------|:----|------------:|:--|:----|---------:|:--|:----|-----------------:|:--|
| Revenues                  |     |   1,824,664 |   |     |   55,275 |   |     |        1,879,939 |   |
| Cost of revenues(*)       |     |  (1,768,503 | ) |     | (151,940 | ) |     |       (1,920,443 | ) |
| Profit/(Loss) per segment |     |      56,159 |   |     |  (96,663 | ) |     |          (40,504 | ) |

There are no transactions between segments for any of the years presented. The revenue breakdown per segment is included in Note 16. For details of concentration of revenue, see Note 3.Substantially all of the Group’s revenues are related to customers in Argentina with a de minimis amount (3.6% of revenues of the Heritas Diagnostics segment in 2024) related to exports to Paraguay and nil for 2023. All of the Group’s assets are located in Argentina. ____________ (*)Below is a breakdown by segment of cost of revenues by nature of expense.

| Year ended June 30, 2024                                     |     |     Heritas 
 Diagnostics |     |  Rewell |     |     Total |
|:-------------------------------------------------------------|:----|------------:|:----|--------:|:----|----------:|
| Laboratory supplies                                          |     |     654,070 |     |  90,351 |     |   744,421 |
| Salaries, social security costs and other